Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 2.500% 6/0
-
Number of holders
-
49
-
Total 13F principal, excl. options
-
693M
-
Principal change
-
+693M
-
Total reported value, excl. options
-
$691M
-
Value change
-
+$691M
-
Number of buys
-
48
-
Price
-
$1.00
Significant Holders of HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q2 2025
49 filings reported holding 405024AD2 - HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q2 2025.
HAEMONETICS CORP MASS - NOTE 2.500% 6/0 has 49 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $693M of principal
.
Largest 10 bondholders include Linden Advisors LP ($164M of principal), Invesco Ltd. ($59.8M of principal), CAMDEN ASSET MANAGEMENT L P /CA ($56.7M of principal), WOLVERINE ASSET MANAGEMENT LLC ($56.3M of principal), ZAZOVE ASSOCIATES LLC ($42.6M of principal), ZAZOVE ASSOCIATES LLC ($42.6M of principal), FRANKLIN RESOURCES INC ($37.4M of principal), Calamos Advisors LLC ($22.5M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($21.7M of principal), and WELLS FARGO & COMPANY/MN ($20.6M of principal).
This table shows the top 49 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.